Delivery Order SPE2DB24D1021-SPE2DB25FFBEH
- Not listed
- The Defense Logistics Agency awarded a $2,366.98 firm fixed price delivery order to AmerisourceBergen Drug Corp for the procurement of Sucralfate 1 GM/10 ML Suspension in a 420 ML quantity. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation and represents a child contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity, with a ceiling value of $2,107.58. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract calls for completion by August 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- This is a delivery order under Contract SPE2DX15D1053 awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for 4,562,782,604 units of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price ceiling of $3,274.80. The contract has an ultimate completion date of November 13, 2023. AmerisourceBergen is a for-profit organization registered in the System for Award Management (SAM.gov)...
- The Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order contract valued at $1,712.24 to provide 420 ml bottles of Sucralfate 1 GM/10 ML suspension. This contract has a completion date of February 28, 2024 and was awarded on February 27, 2024. Amerisourcebergen Drug Corp is the prime contractor for this order, which does not have a small business set-aside designation. This delivery order is likely...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Sucralfate 1 GM/10 ML Suspension, a medical product used for treating certain digestive system conditions. The contract has a ceiling value of $2,060.50 and a completion date of October 27, 2023. The contract is a firm fixed-price delivery order, with no...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $2,227.03, is for the supply of 4,565,891,255 units of Sucralfate 1 GM/10 ML Suspension in 420ML containers. The contract has an ultimate completion date of September 23, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Sucralfate 1 GM/10 ML Suspension in 420 ML bottles, with a firm fixed price of $2,482.57 and a completion date of June 30, 2025. The contract is not a set-aside and is open to full and open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,290.54 firm fixed price delivery order to Amerisourcebergen Drug Corporation for sucralfate oral suspension. The contract calls for the delivery of 420 milliliters of sucralfate 1 gram per 10 milliliters oral suspension to a facility in Conshohocken, Pennsylvania. Performance is required between September 28 and 29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will perform as the prime...
- This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRQXR, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,491.67 firm fixed-price delivery order is for the supply of 420 ml of Sucralfate 1 gm/10 ml suspension, a medication used to treat certain stomach and esophageal conditions. The award is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 420 ml bottles of 1 gm/10 ml sucralfate suspension. The $4,416.88 firm fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical to provide a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFBEHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,314.22 to AmerisourceBergen Drug Corp for the supply of Sucralfate 1 GM/10 ML suspension in a 420 ML quantity. The contract employs firm fixed price terms with no set-aside designation and was competitively awarded on September 26, 2025, with an ultimate completion date of September 29, 2025. Performance will be executed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the company to deliver a broad range of medications, vaccines, medical supplies, and specialty pharmaceuticals to support military healthcare systems worldwide. AmerisourceBergen Drug Corp's consistent receipt of competitively awarded delivery orders across various therapeutic domains demonstrates its established capability to meet federal medical procurement requirements through the DLA's Medical Supply Chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 9/26/25 |